ENaCβ and γ genes as modifier genes in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 7, Issue 1, 2008, Pages 23-29

  Viel, Marion ^a,b   Leroy, Chrystel ^a,b   Hubert, Dominique ^a   Fajac, Isabelle ^a,c   Bienvenu, Thierry ^a,b  

^a Hôpital Cochin ^*  (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CFTR; Cystic fibrosis; ENaC

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; ENDOTHELIUM SODIUM CHANNEL BETA; ENDOTHELIUM SODIUM CHANNEL GAMMA; GLUTAMINE; GLYCINE; ISOLEUCINE; LEUCINE; METHIONINE; SERINE; SODIUM CHANNEL; THREONINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; VALINE; CFTR PROTEIN, HUMAN; EPITHELIAL SODIUM CHANNEL; SCNN1B PROTEIN, HUMAN; SCNN1G PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE SEVERITY; GENE FUNCTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PHENOTYPE; COHORT ANALYSIS; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; GENETICS; HOSPITALIZATION; METABOLISM; PATHOPHYSIOLOGY;

ADULT; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; MUTATION, MISSENSE; NASAL MUCOSA; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 38049107224     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2007.04.003     Document Type: Article

References (31)

1. Cutting G.R. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 6 (2005) 237-260
2. Drumm M.L., Konstan M.W., Schluchter M.D., Handler A., Pace R., Zou F., et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353 (2005) 1443-1453
3. Smith J.J., Travis S.M., Greenberg E.P., and Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85 (1996) 229-236
4. Matsui H., Grubb B.R., Tarran R., Randell S.H., Gatsy J.T., Davis C.W., et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95 (1998) 1005-1015
5. Boucher R.C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 26 (2000) 5-16
6. Firsov D., Gauttschi I., Merillat A.M., Rossier B.C., and Schild L. The heterotetrameric architecture of the epithelial sodium channel (ENAC). EMBO J 17 (1998) 344-352
7. Stutts M.J., Rossier B.C., and Boucher R.C. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem 272 (1997) 14037-14040
8. Chang S.S., Grunder S., Hanukoglu A., Rosler A., Mathew P.M., Hanukoglu I., et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkaliemic conditions acidosis, pseudohypoaldosteronism type 1. Nat Genet 12 (1996) 248-253
9. Hansson J.H., Schild L., Lu Y., Wilson T.A., Gautschi I., Shimkets R., et al. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A 92 (1995) 11495-11499
10. Hanukoglu A., Bistritzer T., Rakover Y., and Mandelberg A. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 125 (1994) 752-755
11. Kerem E., Bistritzer T., Hanukoglu A., Hofmann T., Zhou Z., Bennett W., et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341 (1999) 156-162
12. Bonny O., and Hummler E. Dysfunction of epithelial sodium transport: from human to mouse. Kidney Int 57 (2000) 1313-1318
13. Davidson D.J., Dorin J.R., McLachlan G., Ranaldi V., Lamb D., Doherty C., et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet 9 (1995) 351-357
14. Grubb B.R., and Boucher R.C. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79 (1999) S193-S214
15. Guilbault C., Saeed Z., Downey G.P., and Radzioch D. Cystic fibrosis mouse models. Am J Respir Cell Mol Biol 36 (2007) 1-7
16. Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., and Boucher R.C. In mice. Nat Med 10 (2004) 487-493
17. Sheridan M.B., Fong P., Groman J.D., Conrad C., Flume P., Diaz R., et al. Mutations in the beta subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet 14 (2005) 3493-3498
18. Welsh M.J., and Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73 (1993) 1251-1254
19. Zielenski J., and Tsui L.C. Cystic fibrosis: genotypic and phenotypic variation. Annu Rev Genet 29 (1995) 777-807
20. Rosenstein B.J., and Cutting G.R. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132 (1998) 589-595
21. Moseley C.T., Mullis P.E., Prince M.A., and Phillips J.A. An exon splice enhancer mutation causes autosomal dominant GH deficiency. J Clin Endocrinol Metab 87 (2002) 847-852
22. Cartegni L., and Krainer A.R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30 (2002) 377-384
23. Fajac I., Hubert D., Guillemot D., Honore I., Bienvenu T., Volter F., et al. Normal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax 59 (2004) 971-976
24. Pollard A.J., Krainer A.R., Robson S.C., and Europe-Finner G.N. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3′ splice site. J Biol Chem 277 (2002) 15241-15251
25. Poch E., Gonzalez D., De La Sierra A., Giner V., Bragulat E., Botey A., et al. Genetic variation of the gamma subunit of the epithelial Na+ channel and essential hypertension. Relationship with salt sensitivity. Am J Hypertens 13 (2000) 648-653
26. Shimkets R.A., Warnock D.G., Bositis C.M., Nelson-Williams C., Hansson J.H., and Schambelan M. Liddle's syndrome: heritable human hypertension caused by mutation in the beta subunit of the epithelial sodium channel. Cell 79 (1994) 407-414
27. Furuhashi M., Kitamura K., Adachi M., Miyoshi T., Wakida N., Ura N., et al. Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-unit. J Clin Endocrinol Metab 90 (2005) 340-344
28. Persu A., Barbry P., Bassilana F., Houot A.M., Mengual R., Lazdunski M., et al. Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension. Hypertension 31 (1998) 1118-1124
29. Melander O., Orho M., Fagerudd J., Bengtsson K., Groop P.H., Mattiasson I., et al. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension 32 (1998) 129-137
30. Hannila-Handelberg T., Kontula K., Tikkanen I., Tikkanen T., Fyhrquist F., Helin K., et al. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. BMC Med Genet 6 (2005) 1-13
31. Stanke F., Becker T., Cuppens H., Kumar V., Cassiman J.J.., Jansen S., et al. The TNFα receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet 119 (2006) 331-343